Printer Friendly
The Free Library
19,607,053 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

DENTSPLY International Inc. Reports Completed MRP Filing for Oraqix.


Business Editors/Health/Medical Writers

YORK, Pa.--(BUSINESS WIRE)--April 28, 2004

DENTSPLY International Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:XRAY) today announced that on April 1, 2004 it completed its filing for a Mutual Recognition Procedure (MRP (Material Requirements Planning) An information system that determines what assemblies must be built and what materials must be procured in order to build a unit of equipment by a certain date. ) for Oraqix(TM) in 15 European Union/European Economic Area countries. These include the United Kingdom, France, Germany, Luxembourg, Denmark, Italy, the Netherlands, Finland, Norway, Ireland, Belgium, Spain, Portugal, Iceland and Austria. The MRP allows a filing throughout the EU based on the approval of Marketing Authorization in an EU member country. The filing was validated in all countries and the MRP is now in process.

Oraqix is a revolutionary non-injectable anesthetic for periodontal periodontal /peri·odon·tal/ (per?e-o-don´t'l)
1. pertaining to the periodontal ligament or periodontium.

2. near or around a tooth.


per·i·o·don·tal
adj.
1.
 applications. Oraqix is delivered to the treatment site without the use of a needle and anesthetizes the site within 30 seconds for a period of approximately 20 minutes.

DENTSPLY and its marketing subsidiaries submitted its filing based on the approved marketing authorization received for Oraqix in Sweden on March 7, 2003. Subject to approvals under the MRP, DENTSPLY will work with the individual country regulatory agencies to finalize packaging and patient information leaflets. DENTSPLY expects Oraqix to be marketed in Sweden in the last quarter of 2004 and in the rest of the filed European countries in early 2005.

DENTSPLY designs, develops, manufactures and markets a broad range of products for the dental market. The Company believes that it is the world's leading manufacturer and distributor of dental prosthetics, precious metal dental alloys, dental ceramics, endodontic Endodontic
Pertaining to the inside structures of the tooth, including the dental pulp and tooth root, and the periapical tissue surrounding the root.

Mentioned in: Root Canal Treatment


endodontic
 instruments and materials, prophylaxis prophylaxis (prō'fĭlăk`sĭs), measures designed to prevent the occurrence of disease or its dissemination. Some examples of prophylaxis are immunization against serious diseases such as smallpox or diphtheria; quarantine to confine  paste, dental sealants, ultrasonic scalers, and crown and bridge materials; the leading United States manufacturer and distributor of dental handpieces, dental x-ray film holders, film mounts and bone substitute/grafting materials; and a leading worldwide manufacturer or distributor of dental injectible anesthetics Anesthetics
Drugs or methodologies used to make a body area free of sensation or pain.

Mentioned in: Appendectomy
, impression materials, orthodontic orthodontic (ôr´thdän´tik),
adj
 appliances, dental cutting instruments and dental implants. The Company distributes its dental products in over 120 countries under some of the most well established brand names in the industry.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Apr 28, 2004
Words:322
Previous Article:ON Semiconductor Reports First Quarter Results.
Next Article:Berkshire Hills Bancorp, Inc. Announces Record First Quarter Earnings and Declares Quarterly Dividend.
Topics:



Related Articles
MRP-II software: a selection guide for custom processors.
CIM systems.
Scheduling & MRP: software buyers' guide.
DENTSPLY International, Inc. Announces Agreement to Acquire the Dental Injectible Anesthetic Business of AstraZeneca.
DENTSPLY International Announces Agreement for Acquisition of AstraZeneca's Oraqix Product; and Fourth Quarter Expectations.
DENTSPLY International Inc. Reports FDA Approval of Oraqix --Lidocaine and Prilocaine Gel-- 2.5%/2.5%.
DENTSPLY International Inc. Reports Record Sales and Earnings for 2003 and Fourth Quarter.
DENTSPLY International Inc. Reports Record Second Quarter 2004 Sales and Earnings.
DENTSPLY International Inc. Announces Launch Of Oraqix.
CANGENE COMPLETES MRP FOR WINRHO SDF APPROVAL IN 10 COUNTRIES.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles